| Ticker |
AVDL
|
| CIK | 0001012477 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
| Address | BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, BALLYCOOLIN, DUBLIN, L2, 15 |
| Website | avadel.com |
| Phone | 636-449-1830 |
| CEO | Gregory J. Divis |
| Employees | 70 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Wall Street Analysts Predict a 37.25% Upside in Avadel (AVDL): Here's What You Should KnowThe consensus price target hints at a 37.3% upside potential for Avadel (AVDL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Avadel Pharmaceuticals plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsNasdaqGM:AVDL 1 Year Share Price vs Fair Value Explore Avadel Pharmaceuticals's Fair Values from the Community and... Avadel Pharmaceuticals Second Quarter 2025 Earnings: Beats ExpectationsAvadel Pharmaceuticals ( NASDAQ:AVDL ) Second Quarter 2025 Results Key Financial Results Revenue: US$68.1m (up 64% from... Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)DUBLIN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to eight (8) new employees to purchase 60,400 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employee’s acceptance of employment with Avadel in accordance with Nasda Avadel: Q2 Earnings SnapshotDUBLIN (AP) — Avadel Pharmaceuticals PLC (AVDL) on Thursday reported second-quarter net income of $9.7 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Dublin-based company said it had profit of 10 cents. The results surpassed Wall Street expectations. |
